Gastroenterology Review
eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
abstract:
Original paper

The prevalence of exocrine pancreatic insufficiency in diabetes mellitus – a multicentre study

Roland Kadaj-Lipka
1
,
Marta Wynimko
2
,
Karolina Borowska
2
,
Edward Franek
2, 3
,
Agnieszka Mądro
4
,
Barbara Skrzydło‑Radomańska
4
,
Halina Cichoż­‑Lach
4
,
Barbara Włodarczyk
5
,
Ewa Małecka-Wojciesko
5
,
Elżbieta Czkwianianc
6
,
Krystian Adrych
7
,
Stanisław Głuszek
8, 9, 10
,
Dorota Kozieł
11
,
Grażyna Rydzewska
1, 11

  1. Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  2. Clinical Department of Internal Medicine, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  3. Mossakowski Institute of Clinical Research, Polish Academy of Science, Warsaw, Poland
  4. Department of Gastroenterology and Hepatology with Endoscopy Unit, Medical University of Lublin, Poland
  5. Department of Digestive Tract Diseases, Medical University of Lodz, Poland.
  6. Department of Gastroenterology, Allergology and Pediatrics ICZMP of the Polish Maternal Memorial Hospital Research Institute, Lodz, Poland
  7. Department of Gastroenterology and Hepatology, Medical University of Gdansk, Poland
  8. Department of Surgical Oncology, Holy Cross Cancer Centre, Kielce, Poland
  9. Department of Surgery, Hospital of the Ministry of Interior and Administration, Kielce, Poland
  10. Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland
  11. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev
Online publish date: 2026/05/14
View full text Get citation
 
PlumX metrics:
Introduction
Faecal elastase-1 (FE-1) measurement is a widely utilised screening tool for exocrine pancreatic insufficiency (PEI).

Aim
The present study aimed to assess the prevalence of PEI in diabetic patients and its relationship with diabetes duration, antidiabetic medication use, body mass index, diabetes type, and comorbidities.

Material and methods
A retrospective study was conducted that included 519 patients with type 1 and type 2 diabetes from five medical centres in Poland. The ScheBo® Pancreatic Elastase-1 Quick™ test was utilised for the measurement of faecal elastase-1 levels. Patients with a history of alcohol abuse, gastrointestinal surgery, or pancreatic cancer were excluded from the study. The medical records of the patients were analysed to obtain clinical data.

Results
Among the 519 patients (262 women, 257 men; mean age: 67 years), 20.2% had an FE-1 level < 200 µg/g, indicating PEI. A statistically significant (p > 0.05) higher prevalence of PEI was observed in patients with obesity (BMI > 25 kg/m2). However, no statistically significant association was found between FE-1 levels and factors such as diabetes duration, antidiabetic medication use, or metabolic control. PEI is prevalent in diabetic patients, with a prevalence exceeding 20%. The findings of this study support the rationale for screening for FE-1 in diabetes and suggest that enzyme replacement therapy may be a viable treatment option for patients diagnosed with PEI.

Conclusions
The results of this study imply that PEI is not a late complication of diabetes but may occur independently of disease duration.

keywords:

faecal elastase-1, exocrine insufficiency, exocrine pancreatic insufficiency, diabetes mellitus, diabetic exocrine pancreatopathy, chronic pancreatitis




Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.